美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

iShares Health Innovation Active ETF

33.21

+0.24580.75%

盤後：33.17-0.0408-0.12%16:10 EDT

成交量：534

成交額：1.77萬

市值：1,328.43萬

市盈率：- -

高：33.21

開：33.11

低：33.11

收：32.97

52周最高：34.86

52周最低：25.79

股本：40.00萬

流通股本：40.00萬

量比：0.27

換手率：0.13%

股息：0.08

股息率：0.24%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

博安生物(06955)：BA2201(TL1A/IL-23)臨床試驗申請獲CDE受理

亞虹醫藥：APL-2501臨床試驗申請獲NMPA批准

春雨醫療午前升逾5% 明確AI驅動的數字醫療新賽道

醫保病理雲統一索引正式落地一碼互通賦能精準醫療

醫保病理雲統一索引正式落地一碼互通賦能精準醫療

默沙東(MRK)股票8月25日盤中上漲3.76%：原因全解讀

TradingKey中文

解讀-默克/莫德納癌症疫苗的作用原理及其廣泛應用可能面臨的障礙

Moderna盤初上攻，現大漲近11%，在公司與MRK聯合開發的個體化mRNA癌症疫苗三期臨床試驗數據公布後，多家機構紛

ANNOVIS BIO ：阿爾茨海默病3期臨床試驗已完成全部受試者入組；關鍵數據和申報預計將於2027年完成。

強生公司（JNJ）Imaavy獲FDA標籤擴展用於治療温性自身免疫溶血性貧血

石藥集團(01093)開發的重組呼吸道合胞病毒疫苗(SYS6057)在美國獲臨床試驗批准

石藥集團(01093.HK)開發的重組呼吸道合胞病毒疫苗(SYS6057)在美國獲臨床試驗批准

強生：IMAAVY獲FDA批准用於治療罕見血液疾病

美國食品和藥物管理局擴大了強生公司治療罕見血液疾病藥物的批准範圍

FDA批准Imaavy®成為温自身免疫性溶血性貧血（wAIHA）首創療法，為患者帶來里程碑式突破

REGENXBIO股價下跌24%，此前美國食品藥品監督管理局暫停了該公司針對亨特綜合徵的基因療法的臨床試驗。

衞材公司：Leqembi Iqlik（Lecanemab-Irmb）自動注射器現已在美國上市，用於早期阿爾茨海默病治療啓動

長風藥業(02652)：ICF001於獲國家藥監局臨床試驗默示許可後擴大適應症範圍

智通财经网

巴克萊因莫德納「具有變革性」的黑色素素瘤疫苗潛力上調其目標價

歐盟委員會擴大吉利德Trodelvy®在轉移性三陰性乳腺癌一線治療中的應用範圍，覆蓋所有PD-L1狀態

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/BMED/news?page=9"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BMED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","market":"US","secType":"STK","nameCN":"iShares Health Innovation Active ETF","latestPrice":33.2108,"timestamp":1789416000000,"preClose":32.965,"halted":0,"volume":534,"hourTrading":{"tag":"盘后","latestPrice":33.17,"preClose":33.2108,"latestTime":"16:10 EDT","volume":7,"amount":232.554,"timestamp":1789416603529,"change":-0.0408,"changeRate":-0.001229,"amplitude":0},"delay":0,"changeRate":0.00745639314424376,"floatShares":400000,"shares":400000,"eps":0,"marketStatus":"未開盤","change":0.2458,"latestTime":"09-14 16:00:00 EDT","open":33.11,"high":33.2108,"low":33.11,"amount":17725,"amplitude":0.003058,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789459200000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":32.965,"sharesOutstanding":360000,"nav":32.890304,"aum":13156121.6,"dividendRate":0.0024,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":33.17,"preClose":33.2108,"latestTime":"16:10 EDT","volume":7,"amount":232.554,"timestamp":1789416603529,"change":-0.0408,"changeRate":-0.001229,"amplitude":0},"volumeRatio":0.273566,"impliedVol":0.068,"impliedVolPercentile":0.004},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","floatShares":400000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.273566,"shares":400000,"dividePrice":0.0797,"high":33.2108,"amplitude":0.003058,"preClose":32.965,"low":33.11,"week52Low":25.794,"pbRate":"--","week52High":34.86,"institutionHeld":0,"latestPrice":33.2108,"eps":0,"divideRate":0.0024,"volume":534,"delay":0,"ttmEps":0,"open":33.11,"prevYearClose":30.32,"prevWeekClose":32.965,"prevMonthClose":33.8091,"prevQuarterClose":30.62,"fiveDayClose":34.0304,"twentyDayClose":32.17,"sixtyDayClose":28.4912},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMED\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"BMED","amount":0.08118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Health Innovation Active ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2023-12-20","symbol":"BMED","amount":0.007207,"announcedDate":"2023-12-20","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"BlackRock Future Health ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMED\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.007207,"currency":"USD"},{"executeDate":"2026-06-15","recordDate":"2026-06-15","paymentDate":"2026-06-18","value":0.08118,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMED\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMED\",pageSize:20,pageCount:9,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662713154","title":"博安生物(06955)：BA2201(TL1A/IL-23)臨床試驗申請獲CDE受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2662713154","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662713154?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 19:11","pubTimestamp":1787742677,"startTime":"0","endTime":"0","summary":"智通财经APP讯，博安生物 发布公告，BA2201的新药临床试验申请已获得中国国家药品监督管理局药品审评中心受理。BA2201有望成为中国首批进入临床阶段的TL1A/IL-23双抗药之一。针对上述临床需求，BA2201同时靶向IL-23和TL1A两条核心致病通路。临床前研究显示，BA2201可高效阻断TL1A与DR3的结合;其IL-23结合端亦保持较强的通路抑制活性。此外，BA2201高浓度皮下制剂具有良好稳定性，为临床给药提供便利性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1486228.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","LU1223082196.USD","XME","GDXJ","LU1223083913.SGD","IBBJ","PSYK","SIL","CDE","IBBQ","MDTX","SGDM","BMED","06955","BK4017","LU1223082519.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662790169","title":"亞虹醫藥：APL-2501臨床試驗申請獲NMPA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2662790169","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662790169?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 18:36","pubTimestamp":1787740589,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MDTX","PSYK","IBBQ","BMED","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662649997","title":"春雨醫療午前升逾5% 明確AI驅動的數字醫療新賽道","url":"https://stock-news.laohu8.com/highlight/detail?id=2662649997","media":"新浪港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662649997?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 11:59","pubTimestamp":1787716740,"startTime":"0","endTime":"0","summary":"上月，上市公司“国锐生活”正式更名为“春雨医疗”，标志着国锐生活全面转型AI驱动的全生命周期健康服务平台。半年时间，以传统物业和资产管理为主业的国锐生活，完成了一次跨界收购，将一家拥有70万+医生、近2亿用户的互联网医疗平台收入囊中，更将自身重新定义为一家医疗科技公司，明确了向AI驱动的数字医疗服务平台转型的战略方向。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-08-26/doc-iniprivu5446355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["VTHR","ARTY","LGHT","HTEC","GDOC","00108","BMED","BK1229","HEAL","AIPO","FWD","IEIH","GINN","CHAT","FDHT","AGIX","BK1258","QTOC","FDIF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662832764","title":"醫保病理雲統一索引正式落地 一碼互通賦能精準醫療","url":"https://stock-news.laohu8.com/highlight/detail?id=2662832764","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662832764?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 11:29","pubTimestamp":1787714956,"startTime":"0","endTime":"0","summary":"本次发布的医保病理云索引共设8个部分，总长79位，涵盖全维度核心检查信息，要素全面、精准可溯。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1485793.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["XT","KOMP","HELX","SYNB","GDOC","GNOM","TYNE","DTEC","WDNA","BMED","IDNA","GNMX","HTEC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662648607","title":"醫保病理雲統一索引正式落地 一碼互通賦能精準醫療","url":"https://stock-news.laohu8.com/highlight/detail?id=2662648607","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662648607?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 11:29","pubTimestamp":1787714956,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BMED","TYNE","GDOC","WDNA","HTEC","XT","IDNA","DTEC","SYNB","KOMP","GNOM","GNMX","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662751985","title":"默沙東(MRK)股票8月25日盤中上漲3.76%：原因全解讀","url":"https://stock-news.laohu8.com/highlight/detail?id=2662751985","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662751985?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 02:16","pubTimestamp":1787681783,"startTime":"0","endTime":"0","summary":"• 华尔街分析师上调默克目标价并维持“买入”评级。\n• 与莫德纳合作的试验数据表明，黑色素瘤患者的无复发生存期有所改善。\n• 季度业绩超出市场预期，同时公司上调了全年业绩指引。","market":"fut","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262131028-market-movers-mrk-20260825","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN8TJ469.HKD","IE00BJT1NW94.SGD","SG9999014542.SGD","LU2491050071.SGD","LU0320765646.SGD","LU1585245621.USD","IE00BLSP4452.SGD","LU0122379950.USD","BK4585","LU0648001328.SGD","LU2491050154.USD","LU2361044949.HKD","GDOC","SG9999002232.USD","LU0868494708.USD","LU2491049909.HKD","SG9999015341.SGD","SG9999013999.USD","LU2023250843.SGD","IXJ","SGXZ57979304.SGD","LU1989772840.SGD","MRK","LU1201861249.SGD","LU2361045086.USD","IE00B1BXHZ80.USD","BK4516","LU0965509010.AUD","IE00B2B36J28.USD","LU0070302665.USD","LU0106261372.USD","SG9999001440.SGD","IE00BSNM7G36.USD","LU0477156953.USD","LU0265550359.USD","LU1023059063.AUD","LU0208291251.USD","SG9999015358.SGD","LU2125154778.USD","LU1699723380.USD","LU0289739699.SGD","LU2433249047.HKD","LU1066051811.HKD","LU2461242641.AUD","LU0098860793.USD","LU0266013472.USD","LU1093756325.SGD","LU2357627491.SGD","LU0265550946.USD","IHE","LU2125909247.SGD","LU0234572021.USD","LU2360032135.SGD","SG9999014575.USD","IE00BJJMRZ35.SGD","LU0203347892.USD","LU2468319806.SGD","PPH","LU1974910355.USD","SG9999001176.USD","LU0238689110.USD","LU0432979614.USD","BK4559","LU0203345920.USD","LU0130102774.USD","IE0002141913.USD","LU1571399168.USD","XLV","LU1923622614.USD","IE00BBT3K403.USD","LU0965509101.SGD","IE00BFTCPJ56.SGD","BK4534","LU2106854487.HKD","LU1934455863.HKD","LU0058720904.USD","LU2125154935.USD","LU2089984988.USD","LU0942090050.USD","LU1989771016.USD","LU1983299246.USD","LU1057294990.SGD","LU1061106388.HKD","LU0211331839.USD","LU2023250504.SGD","LU0320765489.SGD","TRUH","LU1093756168.USD","LU1116320901.HKD","IE00B4R5TH58.HKD","BMED","LU2112291526.USD","LU1162221912.USD","IE00BLSP4239.USD","LU1430594728.SGD","LU1929549753.HKD","JDOC","LU2125909593.SGD","LU1066051225.USD","PAWZ","LU0006306889.USD","LU0861579265.USD","RXL","BK4533","LU1934455194.USD","SG9999001176.SGD","LU1291159041.SGD","LU1035773651.USD","LU1941712264.USD","SG9999002224.SGD","IE000M9KFDE8.USD","LU1116320737.USD","VHT","LU1941712348.USD","LU0965509283.SGD","HRTS","IE0009355771.USD","LU0985320562.USD","LU1037948541.HKD","LU1069347547.HKD","SG9999014559.SGD","FTXH","LU0859254822.USD","LU0823416689.USD","LU1934455277.USD","LU1066053197.SGD","LU2361044865.SGD","LU2324357040.USD","LU0130517989.USD","LU0965508806.USD","LU1989772923.USD","BK4007","IYH","LU0868494617.USD","LU1037948897.HKD","LU0980610538.SGD","LU0124676726.USD","LU1066051498.USD","BK4588","LU1917777945.USD","LU0689626769.HKD","SG9999014567.USD","FHLC","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662756120","title":"解讀-默克/莫德納癌症疫苗的作用原理及其廣泛應用可能面臨的障礙","url":"https://stock-news.laohu8.com/highlight/detail?id=2662756120","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662756120?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 00:31","pubTimestamp":1787675475,"startTime":"0","endTime":"0","summary":"解读-默克/莫德纳癌症疫苗的作用原理及其广泛应用可能面临的障碍Mariam Sunny/Christy Santhosh路透8月25日-莫德纳MRNA.O与默克MRK.N正在联合研发的个性化癌症疫苗，让人们对mRNA技术有望开辟一条新的治疗途径  寄予厚望，但目前可用的证据仍然有限。默克和莫德纳目前正在针对肿瘤已通过手术切除的非小细胞肺癌患者开展多项大型临床试验 。莫德纳还在针对膀胱癌和肾癌患者的中期试验中，以及针对胰腺癌和胃癌的早期试验中，研究intismeran与Keytruda的联合疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL4T44M168:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","LU0122379950.USD","LU0124676726.USD","LU0203347892.USD","IXJ","LU0432979614.USD","IHE","LU1989772840.SGD","LU1066051498.USD","LU2468319806.SGD","MRNY","SG9999002224.SGD","SG9999014575.USD","LGHT","LU1941712264.USD","LU0868494708.USD","LU1699723380.USD","IE00BLSP4239.USD","SG9999002232.USD","IE00B2B36J28.USD","LU0868494617.USD","LU2360032135.SGD","LU0689626769.HKD","PAWZ","LU1057294990.SGD","IE00BLSP4452.SGD","LU1093756168.USD","BK4588","LU0320765489.SGD","LU1116320737.USD","LU0823416689.USD","LU2361044865.SGD","GDOC","LU1941712348.USD","LU1066051811.HKD","LU1023059063.AUD","IE00BFTCPJ56.SGD","LU2491050154.USD","PPH","LU0208291251.USD","LU1035773651.USD","LU2125154778.USD","LU2125909247.SGD","LU1037948541.HKD","FTXH","LU2112291526.USD","BK4533","LU2361045086.USD","IE00B4R5TH58.HKD","BK4548","SG9999013999.USD","SG9999001176.SGD","BK4551","IE00BJT1NW94.SGD","IYH","LU1585245621.USD","IDNA","GNOM","SGXZ57979304.SGD","VHT","LU2023250843.SGD","LU2491050071.SGD","LU0006306889.USD","LU2106854487.HKD","FHLC","SG9999014567.USD","LU1291159041.SGD","LU0648001328.SGD","BK4139","LU1983299246.USD","SG9999015358.SGD","IE00BSNM7G36.USD","IE00BN8TJ469.HKD","LU1934455194.USD","LU0965509010.AUD","BK4007","BK4550","LU0130517989.USD","JDOC","LU0266013472.USD","LU1989772923.USD","LU0965508806.USD","LU1989771016.USD","HRTS","LU2433249047.HKD","LU1934455863.HKD","LU1571399168.USD","LU1917777945.USD","BK4585","IE0009355771.USD","LU0265550359.USD","LU1934455277.USD","LU1066053197.SGD","SG9999014542.SGD","BK4568","LU0859254822.USD","LU1430594728.SGD","LU0130102774.USD","LU1061106388.HKD","BK4532","LU1201861249.SGD","LU2361044949.HKD","LU1974910355.USD","LU2357627491.SGD","BMED","LU0320765646.SGD","MRK","LU1066051225.USD","LU0942090050.USD","LU0965509101.SGD","SG9999001440.SGD","IE00B1BXHZ80.USD","IE000M9KFDE8.USD","LU0861579265.USD","MRNA","LU0211331839.USD","BK4516","LU2461242641.AUD","XLV","LU1093756325.SGD","TRUH","LU2491049909.HKD","BK4534","LU0965509283.SGD","LU2324357040.USD","LU0098860793.USD","LU1923622614.USD","LU2125909593.SGD","LU1929549753.HKD","LU2125154935.USD","LU0058720904.USD","LU0106261372.USD","IE00BJJMRZ35.SGD","LU0238689110.USD","LU1116320901.HKD","SG9999015341.SGD","LU0234572021.USD","LU0070302665.USD","LU0980610538.SGD","SG9999014559.SGD","LU1069347547.HKD","MRNX","LU0265550946.USD","LU0477156953.USD","LU0985320562.USD","LU1162221912.USD","SG9999001176.USD","LU2023250504.SGD","BK4559","RXL","WDNA","LU2089984988.USD","BK4501","IE00BBT3K403.USD","LU0203345920.USD","LU0289739699.SGD","LU1037948897.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662675883","title":"Moderna盤初上攻，現大漲近11%，在公司與MRK聯合開發的個體化mRNA癌症疫苗三期臨床試驗數據公布後，多家機構紛","url":"https://stock-news.laohu8.com/highlight/detail?id=2662675883","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662675883?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 21:59","pubTimestamp":1787666388,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1035773651.USD","LU1941712264.USD","LU1066053197.SGD","LU0320765646.SGD","LU1571399168.USD","LU0965509283.SGD","LU0203347892.USD","IE000M9KFDE8.USD","LU0861579265.USD","LU2089984988.USD","LU1430594728.SGD","LU1934455277.USD","LU0965509010.AUD","LU2361044865.SGD","LU1037948897.HKD","IE00BN8TJ469.HKD","IE00BSNM7G36.USD","LU1066051225.USD","LU0124676726.USD","BK4559","LU1934455194.USD","LU0106261372.USD","LU0942090050.USD","SG9999015358.SGD","LU2125154778.USD","WDNA","SGXZ57979304.SGD","IE00BFTCPJ56.SGD","LU0238689110.USD","BK4585","LU1585245621.USD","LU2324357040.USD","LU0868494617.USD","JDOC","MRNY","MRNA","IDNA","LU2491049909.HKD","LU2125154935.USD","LU1037948541.HKD","IE00B4R5TH58.HKD","LU0208291251.USD","BK4516","LU2461242641.AUD","MRNX","BK4501","TRUH","LU0477156953.USD","MRK","RXL","LU1989772840.SGD","LU2491050071.SGD","LU2023250843.SGD","IE00B2B36J28.USD","LU1934455863.HKD","LU0006306889.USD","LU1201861249.SGD","LU2360032135.SGD","SG9999014559.SGD","LU2491050154.USD","GNOM","LU1057294990.SGD","SG9999013999.USD","LU1093756325.SGD","LU1066051811.HKD","LU1983299246.USD","LU1069347547.HKD","LU1917777945.USD","LU0868494708.USD","LU0265550359.USD","PAWZ","XLV","LU0648001328.SGD","IE00BLSP4452.SGD","LU0985320562.USD","LGHT","LU0432979614.USD","BK4139","LU1116320901.HKD","LU2023250504.SGD","BK4588","BK4534","LU1929549753.HKD","IYH","LU2433249047.HKD","LU1023059063.AUD","IE0009355771.USD","LU2361045086.USD","LU1116320737.USD","IE00BJJMRZ35.SGD","LU1066051498.USD","LU0098860793.USD","LU2125909247.SGD","LU2357627491.SGD","BK4568","SG9999002224.SGD","BK4007","LU0234572021.USD","VHT","LU0265550946.USD","LU0859254822.USD","LU1974910355.USD","SG9999001176.SGD","LU0266013472.USD","LU1941712348.USD","IXJ","LU0070302665.USD","LU2106854487.HKD","BK4533","LU2468319806.SGD","LU0203345920.USD","LU0965508806.USD","SG9999001176.USD","BMED","LU2125909593.SGD","LU1699723380.USD","LU0058720904.USD","LU0965509101.SGD","LU0130102774.USD","BK4551","SG9999002232.USD","LU0211331839.USD","SG9999001440.SGD","PPH","SG9999014575.USD","LU1162221912.USD","IHE","SG9999014542.SGD","LU0289739699.SGD","BK4548","LU0980610538.SGD","LU1923622614.USD","BK4550","SG9999014567.USD","LU2361044949.HKD","IE00B1BXHZ80.USD","IE00BJT1NW94.SGD","LU0320765489.SGD","LU1291159041.SGD","LU1989772923.USD","LU1989771016.USD","LU0689626769.HKD","LU0823416689.USD","SG9999015341.SGD","HRTS","LU1061106388.HKD","FHLC","IE00BLSP4239.USD","LU1093756168.USD","GDOC","FTXH","IE0002141913.USD","IE00BBT3K403.USD","LU0130517989.USD","LU2112291526.USD","BK4532","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662340734","title":"ANNOVIS BIO ：阿爾茨海默病3期臨床試驗已完成全部受試者入組；關鍵數據和申報預計將於2027年完成。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662340734","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662340734?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 20:05","pubTimestamp":1787659504,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","MDTX","BIO","LU1169590202.USD","IBBJ","BK4121","BMED","PSYK","BK4585","LU1169589451.USD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662073902","title":"強生公司（JNJ）Imaavy獲FDA標籤 擴展用於治療温性自身免疫溶血性貧血","url":"https://stock-news.laohu8.com/highlight/detail?id=2662073902","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662073902?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 19:17","pubTimestamp":1787656672,"startTime":"0","endTime":"0","summary":"FDA已于今年4月授予Imaavy该项适应症的优先审评资格，本次获批后Imaavy有望成为美国市场首款针对wAIHA的治疗药物。据相关统计，wAIHA发病率约为八千分之一，发病机理为机体自身抗体破坏红细胞，进而引发贫血症状。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210625/YzM5OTgzZmE3NTA3Njg3Nzc4Mjg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/YzM5OTgzZmE3NTA3Njg3Nzc4Mjg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305283","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2347655156.SGD","IHE","JDOC","IE000SO60NU8.SGD","LU1585245621.USD","BK4007","PJP","LU0820561909.HKD","LU0820561818.USD","VHT","LU0210536198.USD","LU1914381329.SGD","LU1221951046.USD","BMED","LU2756315664.SGD","LU2456880835.USD","LU2750360997.AUD","RXL","SG9999001176.SGD","IE00BFTCPJ56.SGD","LABU","IE00BBT3K403.USD","LU2430703251.USD","GDOC","FTXH","LU0795875169.SGD","LU1629891620.HKD","IE00B2B36J28.USD","IE00BLSP4452.SGD","XLV","FHLC","IE00BJJMRZ35.SGD","LU0162691827.USD","BK4534","MEDX","IE00B3PB1722.GBP","IYH","LU0787776722.HKD","TRUH","LU0964807845.USD","LU2505996681.GBP","LU0234572021.USD","LU2602419157.SGD","LU0345769631.USD","IE00B19Z3B42.SGD","IE00BN8TJ469.HKD","JNJ","IXJ","IE00BZ1G4Q59.USD","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662978739","title":"石藥集團(01093)開發的重組呼吸道合胞病毒疫苗(SYS6057)在美國獲臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2662978739","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662978739?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 19:15","pubTimestamp":1787656512,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团 公布，集团开发的预防用生物制品1类新药重组呼吸道合胞病毒疫苗已获得美国食品药品监督管理局批准，可在美国开展临床试验。该产品为该集团第二款获批临床试验的重组蛋白疫苗产品，由呼吸道合胞病毒融合前F蛋白抗原与集团自主研发的第二代纳米佐剂体系组成。本次获批的临床适应症为用于60岁及以上人群预防RSV引起的下呼吸道疾病。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1485247.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B031HY20.USD","LU0326950275.SGD","BK1521","LU1226288170.HKD","PSYK","LU1993786604.SGD","LU0315179316.USD","IE00BZ08YS42.EUR","LU1226288253.USD","LU1152091754.HKD","SG9999004220.SGD","KURE","IE0008368742.USD","BK1515","LU0072913022.USD","LU1328277881.USD","LU0067412154.USD","LU1951186391.HKD","LU0314109678.HKD","IE00BZ08YR35.GBP","LU1226287529.USD","LU1008478684.HKD","BK1191","BMED","HK0000165453.HKD","LU1152091168.USD","IE0008369823.USD","IBBQ","IE00BZ08YT58.USD","01093","IBBJ","LU0501845795.SGD","LU0880133367.SGD","LU1226287875.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU2039709279.SGD","MDTX","159646","LU0140636845.USD","LU1960683339.HKD","LU1226287792.SGD","LU1813983027.USD","LU1807302812.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662073994","title":"石藥集團(01093.HK)開發的重組呼吸道合胞病毒疫苗(SYS6057)在美國獲臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2662073994","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662073994?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 19:15","pubTimestamp":1787656512,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MDTX","BMED","IBBQ","IBBJ","PSYK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662204777","title":"強生：IMAAVY獲FDA批准用於治療罕見血液疾病","url":"https://stock-news.laohu8.com/highlight/detail?id=2662204777","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662204777?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 08:18","pubTimestamp":1787617106,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IHE","LU2487616109.SGD","LU1066053197.SGD","TRUH","LU0985320562.USD","IE00BJT1NW94.SGD","LU1228905037.USD","LU2403377893.USD","FHLC","LU0072461881.USD","XLV","SG9999001176.SGD","FTXH","LABU","BK4588","LU1196500208.SGD","LU1674673691.USD","LU0203345920.USD","SGXZ57979304.SGD","LU1989771016.USD","VHT","BK4592","LU2129689514.USD","LU0640476718.USD","GDOC","BMED","IE0002270589.USD","PJP","LU1228905540.USD","LU1629891620.HKD","IE0009355771.USD","RXL","IE000SO60NU8.SGD","JNJ","BK4568","LU0466842654.USD","LU2896262040.SGD","JDOC","LU1267930813.SGD","IXJ","BK4532","LU1718418525.SGD","LU2468319806.SGD","LU2505996509.AUD","LU0820562030.AUD","MEDX","BK4533","IE0034235303.USD","IYH","LU0320765646.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662720191","title":"美國食品和藥物管理局擴大了強生公司治療罕見血液疾病藥物的批准範圍","url":"https://stock-news.laohu8.com/highlight/detail?id=2662720191","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662720191?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 06:32","pubTimestamp":1787610737,"startTime":"0","endTime":"0","summary":"美国食品和药物管理局扩大了强生公司治疗罕见血液疾病药物的批准范围路透8月24日-强生公司周一表示，美国食品和药物管理局已批准扩大其药物JNJ.N的适应症，用于治疗一种罕见血液疾病。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL4T44L1IL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2505996681.GBP","IXJ","BK4581","LU1145028129.USD","LU1894683264.USD","BK4534","LU1032955483.USD","BK4588","JNJ","LU1061106388.HKD","IE00BSNM7G36.USD","FHLC","LU1221951129.SGD","RXL","BK4504","IE0034235303.USD","BK4585","LU0289739699.SGD","LU0882574055.USD","LU1066053197.SGD","BMED","LU0787776722.HKD","FTXH","LU1989771016.USD","LU2236285917.USD","MEDX","LU0426417589.USD","LU1551013342.USD","IE00BBT3K403.USD","IE00BVYPNW00.USD","SG9999002232.USD","LU2487616109.SGD","IE0002141913.USD","LU2417539215.USD","LU0640476718.USD","IHE","XLV","IE00B19Z3B42.SGD","LU0345769631.USD","GDOC","IYH","LU2456880835.USD","VHT","LU0345769128.USD","LU1228905540.USD","LU1778281490.HKD","JDOC","PJP","TRUH","LU2471134879.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155022349","title":"FDA批准Imaavy®成為温自身免疫性溶血性貧血（wAIHA）首創療法，為患者帶來里程碑式突破","url":"https://stock-news.laohu8.com/highlight/detail?id=1155022349","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155022349?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 06:31","pubTimestamp":1787610685,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局正式批准Imaavy上市，这是首个针对温自身免疫性溶血性贫血的治疗药物，标志着该疾病领域迎来历史性转折。这一批准不仅填补了治疗空白，更为长期缺乏有效方案的患者开辟了全新路径。此项决定源自严格的临床评估，Imaavy的疗效与安全性获得充分验证。如今，Imaavy的问世，有望重塑治疗格局，提升患者生活质量，降低疾病复发风险。wAIHA作为一种罕见病，其治疗困境长期未解，而此药的上市，无疑为患者群体注入了强心剂。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2129689605.HKD","LU2471134879.HKD","XLV","LU1228905540.USD","LU2592432038.USD","LU0912757837.SGD","LU1261432733.SGD","LU0994945656.USD","LU1074936037.SGD","LU0098860793.USD","LU0203347892.USD","LU1732800096.USD","LU0426417589.USD","LU2213496289.HKD","SG9999002224.SGD","LU0689626769.HKD","LU2129689514.USD","LU1894683264.USD","LU2347655156.SGD","LU2750360641.GBP","LU1280957306.USD","SG9999001176.USD","BK4533","LU2471134796.USD","LU2417539215.USD","BK4534","LU2487616109.SGD","LU2750360997.AUD","LU0466842654.USD","SG9999013999.USD","LU0820561909.HKD","SGXZ57979304.SGD","IE00B3T34201.USD","LU0122379950.USD","IE0034235303.USD","LU0124676726.USD","GDOC","LU1989771016.USD","LU2023250330.USD","LU2236285917.USD","LU0792757196.USD","LU2471134952.CNY","BK4532","LU1057294990.SGD","LU1059921491.USD","LU1043141396.HKD","VHT","LU1929549753.HKD","LU1778281490.HKD","LU0058720904.USD","LU0889566641.SGD","LU2403377893.USD","IE000M9KFDE8.USD","LU2756315664.SGD","LU0820562030.AUD","LU1023059063.AUD","LU0320765646.SGD","IE000WAW04H5.SGD","IE00BSNM7G36.USD","IE00B42XCP33.USD","LU0795875169.SGD","LU0882574055.USD","IE000SO60NU8.SGD","LU2505996509.AUD","RXL","LU0432979614.USD","BMED","LU2133065610.SGD","IE00BGHQF631.EUR","LU0234570918.USD","BK4504","LU1228905037.USD","JDOC","IE00BKVL7J92.USD","IXJ","BK4568","SG9999001176.SGD","LU0795875086.SGD","LU1066051225.USD","IE00B4R5TH58.HKD","IE00B7SZLL34.SGD","LU0072461881.USD","LU0114720955.EUR","LU1244550494.USD","LU1629891620.HKD","IE0009355771.USD","LU1196500208.SGD","LU2112291526.USD","JNJ","LU0683600562.USD","LU0345769631.USD","LU1032466523.USD","LU2471134523.USD","LU1732799900.SGD","LU2602419157.SGD","LU2468319806.SGD","FHLC","IE0001KFT4U8.USD","LU1496350502.SGD","LU1430594728.SGD","LU1061106388.HKD","LU0210528500.USD","IE00B3PB1722.GBP","IE00BJJMRZ35.SGD","IE00BVYPNW00.USD","LU0345770993.USD","BK4559","IE00BZ1G4Q59.USD","LU1914381329.SGD","IE000F7OJYX1.SGD","IE0002270589.USD","IHE","LU1718418525.SGD","IE0000B7K699.USD","IE000BZT7R73.USD","LU0203345920.USD","LU1585245621.USD","IE00B19Z3B42.SGD","TRUH","LU1244550577.SGD","LU1551013425.SGD","LU0234572021.USD","LU0210536198.USD","IE00B2B36J28.USD","LU1066053197.SGD","LU0689472784.USD","LU1032955483.USD","LU1121112475.USD","IE000MB6IJN5.SGD","BK4585","LU0820561818.USD","LU0070217475.USD","LU1291159041.SGD","LU1162221912.USD","IE00BBT3K403.USD","LU0787776722.HKD","LU0964807845.USD","IE00BDGV0183.EUR","LU1145028129.USD","LU2129689431.USD","LU2430703251.USD","IE00B1BXHZ80.USD","LU1043141123.HKD","LU2430703095.HKD","LU1244550221.USD","LU1221951046.USD","LU1674673428.USD","LU0545562505.USD","LU2430703178.SGD","LU0985320562.USD","LU2896262040.SGD","BK4592","FTXH","LU0345770308.USD","LU1221951129.SGD","LU0426412945.USD","IYH","IE00BJT1NW94.SGD","LU0345769128.USD","LU1066051811.HKD","LU1066051498.USD","LU1983299246.USD","LU0289739699.SGD","IE00BFTCPJ56.SGD","IE00BLSP4452.SGD","LU1551013342.USD","LU2756315318.SGD","LU0943347566.SGD","LU0162691827.USD","BK4007","IE0002141913.USD","IE00BLSP4239.USD","LU2089984988.USD","LU1894683348.USD","LU2456880835.USD","MEDX","LU1506573853.SGD","IE00BN8TJ469.HKD","BK4550","IE00B19Z3581.USD","LU1674673691.USD","SG9999001440.SGD","IE00BVYPNV92.GBP","LU0640476718.USD","SG9999002232.USD","LU1935042991.SGD","LU0053666078.USD","BK4588","PJP","BK4581","SGXZ80539844.SGD","IE00BFXG1179.USD","LU2505996681.GBP","LU1267930813.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661271420","title":"REGENXBIO股價下跌24%，此前美國食品藥品監督管理局暫停了該公司針對亨特綜合徵的基因療法的臨床試驗。","url":"https://stock-news.laohu8.com/highlight/detail?id=2661271420","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661271420?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 21:32","pubTimestamp":1787578348,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BMED","CNCR","MDTX","PSYK","IBBJ","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169385922","title":"衞材公司：Leqembi Iqlik（Lecanemab-Irmb）自動注射器現已在美國上市，用於早期阿爾茨海默病治療啓動","url":"https://stock-news.laohu8.com/highlight/detail?id=1169385922","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169385922?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 20:04","pubTimestamp":1787573051,"startTime":"0","endTime":"0","summary":"卫材株式会社宣布，其用于启动早期阿尔茨海默病治疗的Leqembi Iqlik自动注射器，现已正式登陆美国市场。与传统的静脉输注方式相比，这款自动注射器的问世，无疑为治疗流程的优化开辟了新的路径。随着该产品在美国的落地，早期阿尔茨海默病患者及其家庭或将迎来更为主动、可控的疾病管理体验。市场观察人士认为，这一创新给药方式的引入，或将对现有治疗格局产生积极而深远的影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU0234570918.USD","LU0320765992.SGD","BK4532","IE00B19Z9Z06.USD","BK4585","IE00B894F039.SGD","BK4533","IE00B19Z9P08.USD","BMED","BK4139","BK4588","PBE","LU0109394709.USD","BIIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661756722","title":"長風藥業(02652)：ICF001於獲國家藥監局臨床試驗默示許可後擴大適應症範圍","url":"https://stock-news.laohu8.com/highlight/detail?id=2661756722","media":"智通财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661756722?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 19:37","pubTimestamp":1787571455,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长风药业 发布公告，集团自主研发的长效吸入干粉候选药物ICF001已获中华人民共和国国家药品监督管理局就间质性肺病开展临床试验的临床试验默示许可。上述许可乃继该产品于2026年3月就肺动脉高压及间质性肺病相关肺高压取得国家药监局临床试验默示许可之后取得。该产品现已获准就涵盖肺血管疾病及进行性纤维化肺病的四项适应症开展临床研究。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484419.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02652","PSYK","MDTX","IBBQ","BMED","BK1191","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661273989","title":"巴克萊因莫德納「具有變革性」的黑色素素瘤疫苗潛力上調其目標價","url":"https://stock-news.laohu8.com/highlight/detail?id=2661273989","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661273989?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 19:05","pubTimestamp":1787569505,"startTime":"0","endTime":"0","summary":"BUZZ-巴克莱因莫德纳“具有变革性”的黑色素素瘤疫苗潜力上调其目标价8月24日-** 巴克莱将疫苗制造商莫德纳（MRNA.O）的目标价从48美元上调至125美元，维持“中性”评级** 新目标价较该股上周五收盘价仍有13.9%的下行空间** 此次上调目标价发生在莫德纳和默克公司MRK.N联合宣布其共同开发的皮肤癌疫苗晚期临床试验取得 (link) 突破性成果一周之后，该试验表明，实验性疗法Inti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL4S44L0RI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106261372.USD","LU2433249047.HKD","LU2125154935.USD","LU0124676726.USD","BK4548","LU0965508806.USD","BK4559","LU1116320901.HKD","SG9999001176.SGD","IYH","IDNA","LU2361045086.USD","SG9999014567.USD","MRK","LU0058720904.USD","LU0266013472.USD","LU2125909593.SGD","IE00BJT1NW94.SGD","LU1989771016.USD","FTXH","IE00BSNM7G36.USD","IE00BJJMRZ35.SGD","LU1093756325.SGD","LU1116320737.USD","FHLC","LU2125909247.SGD","SG9999001440.SGD","LU2461242641.AUD","LU0965509101.SGD","SG9999014542.SGD","LU0477156953.USD","LU2324357040.USD","SG9999002232.USD","SGXZ57979304.SGD","SG9999002224.SGD","LU1061106388.HKD","IE000M9KFDE8.USD","LU1934455863.HKD","LU1430594728.SGD","IE00B1BXHZ80.USD","SG9999015341.SGD","LU1989772840.SGD","LU0070302665.USD","PPH","LU1941712348.USD","LU1201861249.SGD","GDOC","LU0965509010.AUD","LU0320765646.SGD","BK4532","LU0208291251.USD","LU1066051811.HKD","LU1035773651.USD","LU1929549753.HKD","SG9999014559.SGD","BMED","LU0868494708.USD","LU1093756168.USD","IE00BBT3K403.USD","MRNX","MRNA","LU0965509283.SGD","GNOM","LU0130517989.USD","LU0985320562.USD","BK4550","LU2468319806.SGD","HRTS","IXJ","SG9999014575.USD","XLV","LU1585245621.USD","IE00B2B36J28.USD","LU2491050154.USD","IE00BLSP4452.SGD","TRUH","LU1291159041.SGD","LU2023250843.SGD","LU1066053197.SGD","LU0122379950.USD","LU0320765489.SGD","IE00B4R5TH58.HKD","MRNY","IE00BLSP4239.USD","BK4007","IE0002141913.USD","LU1069347547.HKD","LU1983299246.USD","LU2491050071.SGD","LU0432979614.USD","PAWZ","LU2491049909.HKD","LU1934455277.USD","JDOC","LU1037948897.HKD","LU1066051498.USD","LU0265550359.USD","IHE","BK4551","SG9999001176.USD","LU0130102774.USD","RXL","LU2089984988.USD","LU0238689110.USD","LU1057294990.SGD","LU2361044865.SGD","LU0861579265.USD","LU0203347892.USD","LU0689626769.HKD","LU0823416689.USD","IE00BFTCPJ56.SGD","LU0203345920.USD","VHT","LU1699723380.USD","BK4585","LU0980610538.SGD","BK4588","BK4533","LU1066051225.USD","LU1923622614.USD","BK4139","BK4568","LU2361044949.HKD","LGHT","BK4516","LU0868494617.USD","LU1989772923.USD","SG9999013999.USD","IE0009355771.USD","LU1037948541.HKD","LU0859254822.USD","LU1917777945.USD","LU1162221912.USD","LU0098860793.USD","WDNA","LU2360032135.SGD","LU1571399168.USD","LU1974910355.USD","SG9999015358.SGD","LU0289739699.SGD","LU0006306889.USD","BK4534","LU1934455194.USD","LU0234572021.USD","LU1941712264.USD","LU1023059063.AUD","LU0648001328.SGD","LU0942090050.USD","IE00BN8TJ469.HKD","LU2112291526.USD","LU2125154778.USD","LU0211331839.USD","BK4501","LU0265550946.USD","LU2357627491.SGD","LU2023250504.SGD","LU2106854487.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186632498","title":"歐盟委員會擴大吉利德Trodelvy®在轉移性三陰性乳腺癌一線治療中的應用範圍，覆蓋所有PD-L1狀態","url":"https://stock-news.laohu8.com/highlight/detail?id=1186632498","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186632498?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 18:32","pubTimestamp":1787567559,"startTime":"0","endTime":"0","summary":"欧盟委员会近日作出重要决定，将吉利德科学（Gilead Sciences）旗下重磅药物Trodelvy®的适用范围进一步拓宽。此次调整聚焦于转移性三阴性乳腺癌的一线治疗领域，且不再受限于患者的PD-L1表达状态。这一举措意味着，无论生物标志物检测结果如何，符合条件的患者均有望从该疗法中获益。此举不仅为临床医生提供了更为灵活的用药选择，也标志着Trodelvy®在肿瘤治疗版图中的地位得到显著提升。吉利德科学方面对此表示积极回应，认为该批准将助力满足更多患者未被满足的医疗需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965509283.SGD","LU1839511570.USD","GILD","LU1037948541.HKD","IE0002270589.USD","LU2357627491.SGD","LU2089984988.USD","LU1037948897.HKD","LU0889565916.HKD","BK4532","LU0289739699.SGD","IE00B19Z3B42.SGD","LU0320765992.SGD","LU1023059063.AUD","LU0058720904.USD","LU0823416689.USD","SG9999015945.SGD","LU2087621335.USD","BK4578","BK4585","LU0861579265.USD","TBXU","IE00B3T34201.USD","LU0859254822.USD","BBH","LU1430594728.SGD","LU1934455863.HKD","LU2324357040.USD","BK4139","IE00BSNM7G36.USD","LU0882574055.USD","LU1066051498.USD","LU0234570918.USD","IBBQ","IE00B7SZLL34.SGD","BK4583","BMED","LU2112291526.USD","BK4566","BIB","LU0965508806.USD","LU0965509101.SGD","BK4550","IE00B19Z3581.USD","LU1778281490.HKD","LU1057294990.SGD","LU1934455194.USD","LU1066053197.SGD","IE00BKVL7J92.USD","LU0109394709.USD","LU0965509010.AUD","SG9999015978.USD","LU0114720955.EUR","SG9999015952.SGD","IE00BZ1G4Q59.USD","BK4568","LU1674673428.USD","MEDI","IBB","LU0122379950.USD","BK4588","LU1571399168.USD","LU1585245621.USD","LU1934455277.USD","LU1674673691.USD","LU2468319806.SGD","SG9999015986.USD","TMED","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}